Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: An immunohistochemical study

Pathology Research and Practice

Volumn 196, Issue 1, 2000, Pages 15-21

  Dietzmann, K ^a   Bossanyi, P V ^a   Krause, D ^a   Wittig, H ^a   Mawrin, C ^a   Kirches, E ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Astrocytes; Brain degradation; Laminin; Microglia; Necrosis; Neurotrauma; Plasminogen activator inhibitor; Plasminogen activator system; Serine proteases; Tetranectin

Indexed keywords

ALTEPLASE; LAMININ; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 2; TETRANECTIN; UROKINASE;

ADULT; AGED; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PLASMINOGEN ACTIVATION; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

EID: 0033958906     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(00)80017-5     Document Type: Article

References (50)

1. Anthony DC, Ferguson B, Matyzak MK, Miller KM, Esiri MM, Perry VH (1997) Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 23: 406-415
2. Blomgren K, McRae A, Elmered A, Bona E, Kawashima S, Saido TC, Ono T, Hagberg H (1997) The calpian proteolytic system in neonatal hypoxic-ischemia. Ann NY Acad Sci 15: 825; 104-109
3. Boudaoud L, Roussi J, Lortat-Jacob S, Bussel B, Dizien O, Drouet L (1997) Endothelial fibrinolytic reactivity and the risk of deep thrombosis after spinal cord injury. Spinal Cord 15: 151-157
4. Chen ZL, Strickland S (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91: 917-925
5. Clemmensen I, Petersen LC, Kluft C (1986) Purification and characterization of a novel, oligomeric, plasmogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem 156: 327-333
6. Christensen L, Clemmensen I (1989) Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme. Histochemistry 92: 29-35
7. Churliaev IUA, Lychev VG, Pavlenko AA, Epifantseva NN, Chepizko SIA, Kovalenko VM, Karagaeva LG (1996) The possible mechanisms of a fibrinolytic disorder in patients with severe craniocerebral trauma. Anesteziol Reanimatol 1: 37-39
8. Constantini V, Sidoni A, Devglia R, Cazzato OA, Bellezza G, Ferri I, Bucciarelli E, Nenci GG (1996) Combined overexpression of urokinase, urokinase receptor and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign and malignant breast tissues. Cancer 77: 1079-1088
9. Cunningham DD, Pulliam L, Vaugham P (1993) Protease nexin-1 and thrombin: Injury related process in the brain. Thromb-Haemostasis 70: 168-171
10. Dano K, Andreasen A, Grondahl-Hansen J, Kristensen P, Nielsen L, Skriver L (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139-266
11. Di X, Harpold T, Watson JC, Bullock MR (1996) Excitotoxic damage in neurotrauma: Fact or fiction? Restor Neurol Neurosci 9: 231-241
12. Edgar D (1991) The expression and distribution of laminin in the developing nervous system. J Cell Science (Suppl.) 15: 9-12
13. Faber-Elman A, Miskin R, Schwartz M (1995) Components of the plasminogen activator system in astrocytes are modulated by tumor necrosis factor-alpha and interleukin-1 beta through similar transduction. J Neurochem 65: 1524-1535
14. Goldberg WJ, Levine KV; Tadvalkar G, Laws ER, Bernstein JJ (1992) Mechanisms of C6 glioma cell and fetal astrocyte migration into hydrated collagen I gels. Brain Res 581: 81-90
15. Hibino T, Izaki S, Ohkuma M, Kon S, Thorsen S, Astedt B (1988) Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2. FEBS-Lett. 231: 202-206
16. Hogdall CK (1998) Human tetranectin: methodological and clinical studies. APMIS Suppl. 86: 1-31
17. Kampfl A, Posmantur R, Nixon R, Grynspan F, Zhao X, Liu SJ, Newcomb JK, Clifton GL, Hayes RL (1996) mucalpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J Neurochem 67: 1575-1583
18. Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff D (1993) Cellular localization of type-1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 142: 59-69
19. Kinder DH, Berger MS, Mueller BA, Silber JR (1993) Urokinase plasminogen activator is elevated in human astrocytic gliomas relative to normal adjacent brain. Oncol Res 5: 409-414
20. Kobayashi H, Fujishiro S, Terao T (1994) Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res 54: 6539-6548
21. Kristensen P, Nielsen L, Grondahl-Hansen J, Andresen P, Larsson L, Dano K (1985) Immunocytochemical demonstration of tissue-type-plasminogen activator in endocrine cells of the pituitary gland. J Cell Biol 101: 305-311
22. Masos T, Miskin R (1997) mRNA encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. Brain-Res-Mol-Brain Res 47. 157-169
23. MacDonald RL, Weir BKA, Young JD, Grace MG (1992) Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoidal hemorrhages in monkeys. J Neurosurg 76: 81-90
24. McCulloch J, Ozyurt E, Kun Park C, Nehls DG, Teashale GM, and Graham DI (1993) Glutamate receptor antagonists in experimental focal cerebral ischaemia. Acta Neurochir 57: 73-79
25. McIntosh TK, Smith DH, Meaney DF, Kotapka MJ, Gennarelli TA, Graham DI (1996) Neuropathological sequelae of traumatic brain injury: Relationship to neurochemical and biomechanical mechanisms. Lab Invest 74: 315-342
26. Mohanam S, Sawaya RE, McCutcheon I, Ali-Osman F, Boyed D, Rao J (1993) Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53: 4143-4147
27. Mori S, Sternberger NH, Herman MM, Sternberger LA (1992) Variability of laminin immunoreactivity in human autopsy brain. Histochemistry 97: 237-241
28. Murphy P, Hart DA (1992) Modulation of plasminogen activator and plasminogen activator inhibitor expression in the human U373 glioblastoma/astrocytoma cell line by inflammatory mediators. Exp Cell Res 198: 93-100
29. Murtomaki S, Trenkner E, Wright JM, Saksela O, Liesi P (1995) Increased proteolytic activity of the granule neurons may contribute to neuronal death in the weaver mouse cerebellum. Dev Biol 168: 635-648
30. Nakajima K, Tsuzaki N, Shimojo M, Hamanoue M, Kohsaka S (1992) Microglia isolated from rat brain secrete a urokinase-type-plasminogen activator. Brain Res 17: 285-292
31. Presta M, Ennas MG, Torelli S, Ragnotti G, Gremo F (1990) Synthesis of urokinase-type plasminogen activator and of type-1 plasminogen activator inhibitor in neuronal cultures of human fetal brain: stimulation by phorbol ester. J Neurochem 55: 1647-1654
32. Rami A, Ferger D, Kriegelstein J (1997) Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity. Neurosci Res 27: 93
33. Reith A, Rucklidge GJ (1992) Invasion of brain tissue by primary glioma: Evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase. Biochem Biophys Res Commun 186: 348-354
34. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression after cerebral focal ischemia in rats: Inhibition of matrixmetalloproteinase-9 reduces infarct size. Stroke 29: 1020-1030
35. Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG (1995) Tumor necrosis factor alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 703. 151-155
36. Saatman KE, Bozyczko-Coyne D, Marcy V, Siman R, McIntosh TK (1996) Prolonged calpain mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J Neuropathol Exp Neurol 55: 850-860
37. Sakata Y, Okada M, Nor A, Matsuda M (1988) Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells. J Biol Chem 263: 1060-1069
38. Saksela O, Hovi T, Vaheri A (1985) Urokinase-type-plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J Cell Physiol 122: 125-132
39. Seeds NW, Friedman G, Hayden S, Thewke D, Haffke S, McGuire P, Krystosek A (1996) Seminars in the Neurosciences. Semin Neurosci 8: 405-412
40. Seubert P, Ivy G, Larson J, Lee J, Shahi K, Baudry M, Lynch G (1988) Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus. I Biochemical studies. Brain Res 459: 226-232
41. Seyfried D, Han Y, Zheng Z, Day N, Moin K, Rempel S, Sloane B, Chopp M (1997) Cathepsin B and middle cerebral artery occlusion in the rat. J Neurosurg 87: 716-723
42. Stephens R, Tapiovaara H, Alitalo R, Reisberg T, Lymboussakis A, Myöhänen H, Vaheri A (1992) Cell-surface plasminogen activation and leukemia. Fibrinolysis 6: 35-39
43. Tranque P, Naftolin F, Robbins R (1994) Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-I and epidermal growth factor. Endocrinology 134: 2606-2613
44. Tsirka SE (1997) Clinical implications of involvement of tPA in neuronal cell death. J Mol Med 75: 341-347
45. Van-Der-Laan LJW, De Groot CJA, Elices MJ, Dijkstra CD (1997) Extracellular matrix protein expressed by human adult astrocytes in vivo and in vitro: An astrocyte surface protein containing the CS1 domain contributes to binding of lymphoblasts. J Neurosci Res. 50: 539-548
46. Vassalli JD, Sappino A, Belin D (1991) The plasminogen activator/plasmin system. J Clin Invest 88: 1067-1072
47. Wahl W, Schilling L, Unterberg A, Baethmann A (1993) Mediators of vascular and parenchymal mechanisms in secondary brain damage. Acta Neurochir 57. 64-72
48. Wang YF, Triska SE, Strickland S, Stieg PE, Soriano SG, Lipton SA (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild type and tPA-deficient mice. Nat Med 4: 228-231
49. Ware JH, DiBenedetto AJ, Pittman RN (1995) Localization of tissue plasminogen activator mRNA in the developing rat cerebellum and effects of inhibiting tPA on granule cell migration. J Neurobiol 28: 9-22
50. Yamamoto M, Sawaya RE, Mohanam S, Rao VH, Brunner JM, Nicolson GL, Rao JS (1994) Expression and localisation of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res 54: 5016-5020